Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Health
Adam Eckert

DARK SECRETS: Why novavax shares are rising today | Vintage Vibes

Novavax Inc (NASDAQ:NVAX) is trading higher Monday after the company submitted a request to the U.S Food and Drug Administration for Emergency Use Authorization of its COVID-19 vaccine, NVX-CoV2373.

Novavax's submission includes the results from two large pivotal clinical trials which demonstrated approximately 90% overall efficacy. In both trials, the vaccine demonstrated efficacy with a reassuring safety profile, according to the company.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.